Related Experiment Video
Updated: May 8, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Cardiovascular changes during chronic hypertensive states
Dorota Drozdz1, Kalina Kawecka-Jaszcz
1Dialysis Unit, Jagiellonian University Medical College, 265 Wielicka Str., 30-663, Krakow, Poland, dadrozdz@cm-uj.krakow.pl.
Insights
High blood pressure (hypertension) is a key risk factor for heart and kidney disease. Early detection of target organ damage in children with hypertension is crucial for preventing cardiovascular events.
Area of Science:
- Cardiology
- Nephrology
- Pediatrics
Background:
- Elevated blood pressure is a significant risk factor for cardiovascular diseases, including coronary heart disease, heart failure, and stroke.
- Hypertension's duration and severity influence target organ damage, with effects detectable even in childhood.
- Cardiovascular diseases are the leading cause of mortality in patients with chronic kidney disease (CKD).
Purpose of the Study:
- To highlight the importance of antihypertensive therapy in preventing cardiovascular events.
- To emphasize that intermediate target organ damage is detectable in childhood.
- To underscore the need for nephroprotection and cardioprotection in pediatric and adult CKD patients.
Main Methods:
- Review of established knowledge on hypertension and cardiovascular risk.
- Analysis of target organ damage in pediatric populations with hypertension.
- Examination of cardiovascular risk factors in chronic kidney disease patients.
Main Results:
- Intermediate target organ damage, such as left ventricular hypertrophy, is present in childhood.
- Children with CKD are particularly susceptible to long-term cardiovascular risk factors.
- Cardiovascular morbidity and mortality are high in young adults with a history of childhood CKD.
Conclusions:
- Antihypertensive treatment aims to reduce global cardiovascular event risk.
- Early detection and management of hypertension and its target organ damage in children are essential.
- Integrated nephroprotection and cardioprotection strategies are vital for improving outcomes in pediatric and adult CKD patients.
Abstract:
It is well established that elevated blood pressure constitutes a major risk factor for coronary heart disease, arrythmias, heart failure, cerebrovascular disease, peripheral artery disease and renal failure. Blood pressure level and the duration of arterial hypertension (HTN) impact target organ damage. Many studies in adults have demonstrated the role of antihypertensive therapy in preventing cardiovascular (CV) events. The so-called hard end-points, such as death, myocardial infarction (MI) or stroke, are rarely seen in children, but intermediate target organ damage, including left ventricular hypertrophy, increased intima-media thickness and microalbuminuria, is already detectable during childhood. The goal of antihypertensive treatment is to reduce the global risk of CV events. In the adult population stratification of CV risk is based on blood pressure level, risk factors, subclinical target organ damage and established CV and kidney disease. Increased CV risk begins early in the course of kidney disease, and CV diseases are the most frequent cause of morbidity and mortality in patients with chronic kidney disease (CKD). Children with CKD are especially prone to the long-term effects of CV risk factors, which result in high morbidity and mortality in young adults. To improve the outcome, pediatric and adult CKD patients require nephro- and cardioprotection.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
